TNET vs. MEDP, RTO, ULS, STN, CART, BILI, HQY, FOUR, LIF, and LYFT
Should you be buying TriNet Group stock or one of its competitors? The main competitors of TriNet Group include Medpace (MEDP), Rentokil Initial (RTO), UL Solutions (ULS), Stantec (STN), Maplebear (CART), Bilibili (BILI), HealthEquity (HQY), Shift4 Payments (FOUR), Life360 (LIF), and Lyft (LYFT). These companies are all part of the "business services" industry.
TriNet Group vs. Its Competitors
TriNet Group (NYSE:TNET) and Medpace (NASDAQ:MEDP) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability.
Medpace has lower revenue, but higher earnings than TriNet Group. TriNet Group is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.
TriNet Group presently has a consensus price target of $96.33, indicating a potential upside of 40.63%. Medpace has a consensus price target of $422.27, indicating a potential downside of 13.96%. Given TriNet Group's higher possible upside, research analysts clearly believe TriNet Group is more favorable than Medpace.
In the previous week, Medpace had 20 more articles in the media than TriNet Group. MarketBeat recorded 22 mentions for Medpace and 2 mentions for TriNet Group. TriNet Group's average media sentiment score of 1.71 beat Medpace's score of 1.27 indicating that TriNet Group is being referred to more favorably in the media.
TriNet Group has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, Medpace has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500.
Medpace has a net margin of 18.74% compared to TriNet Group's net margin of 2.85%. TriNet Group's return on equity of 208.35% beat Medpace's return on equity.
96.8% of TriNet Group shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 37.1% of TriNet Group shares are owned by insiders. Comparatively, 20.3% of Medpace shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
Medpace beats TriNet Group on 10 of the 16 factors compared between the two stocks.
Get TriNet Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for TNET and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TNET and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
TriNet Group Competitors List
Related Companies and Tools
This page (NYSE:TNET) was last updated on 9/17/2025 by MarketBeat.com Staff